NASDAQ:AEZS
AEterna Zentaris Inc. Stock News
$2.19
+0.110 (+5.29%)
At Close: Mar 28, 2024
Aeterna Zentaris Provides Update on Ongoing Pivotal Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
12:05pm, Monday, 21'st Mar 2022 GlobeNewswire Inc.
– Company actively monitoring delays to mitigate potential impact of COVID-19 and conflict in Ukraine following Russian invasion on the estimated completion dates for the trial
Synlogic, Inc. (SYBX) Reports Q4 Loss, Misses Revenue Estimates
12:25pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Synlogic, Inc. (SYBX) delivered earnings and revenue surprises of 22.22% and 1.33%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
ANI Pharmaceuticals (ANIP) Lags Q4 Earnings Estimates
01:15pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
ANI (ANIP) delivered earnings and revenue surprises of -34.15% and 4.60%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Beholding Stock: Cinedigm Corp. (NASDAQ:CIDM), Aeterna Zentaris Inc. (NASDAQ:AEZS)
06:53am, Friday, 11'th Mar 2022 Stock Equity
Cinedigm Corp. (NASDAQ:CIDM) with the stream of -1.11% also noticed, India Aeterna Zentaris Inc. (NASDAQ:AEZS) encountered a rapid change of -0.97% in the last hour of Thursday’s trading session. Cinedigm … The post Beholding Stock: Cinedigm Corp. (NASDAQ:CIDM), Aeterna Zentaris Inc. (NASDAQ:AEZS) appeared first on Stocks Equity .
Aeterna Zentaris expands research program for COVID-19/Chlamydia vaccines
01:33pm, Thursday, 10'th Mar 2022 Seeking Alpha
Aeterna Zentaris (AEZS) expanded its existing research program with the Julius-Maximilians-University Wuerzburg ((JMU)) on the development of COVID-19 and Chlamydia…
Aeterna Zentaris Announces Expansion of Research Program with Julius-Maximilians-University Wuerzburg Aiming to Accelerate Development of Vaccine Programs
12:05pm, Thursday, 10'th Mar 2022 GlobeNewswire Inc.
– Research agreement expanded for development of human 3D intestinal tissue models to study Salmonella enterica pathogenesis
Zoya''s marquee collection Aeterna is an ode to infinite feminine energy
07:30am, Tuesday, 08'th Mar 2022 Business Standard
Mumbai (Maharashtra) [India], March 8 (ANI/NewsVoir): Zoya, the exquisite diamond boutique from the House of Tata, introduces Aeterna a contemporary collection of rare jewellery that traces inspiration from ancient symbols of sacred geometry. Often described as a blueprint of the universe these symbols have captivated artists and philosophers across cultures and through the ages.
Aeterna Zentaris to get US patent for potential hormone disorder therapy AEZS-150
02:42pm, Wednesday, 02'nd Mar 2022 Seeking Alpha
Aeterna Zentaris <> said its licensor, The University of Sheffield received a notice of allowance from the U.S. Patent and Trademark Office ((USPTO)).The patent application No
Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic Hypoparathyroidism
01:05pm, Wednesday, 02'nd Mar 2022 GlobeNewswire Inc.
– Notice of allowance received by Company’s licensor, The University of Sheffield (UK) bolsters intellectual property of AEZS-150 in development for the potential treatment of chronic hypoparathyr
Aeterna Zentaris Announces Notice of Allowance for U.S. Patent Covering AEZS-150 for the Potential Treatment of Chronic Hypoparathyroidism
01:05pm, Wednesday, 02'nd Mar 2022 GlobeNewswire
– Notice of allowance received by Company’s l icensor, The University of Sheffield (UK) bolsters intellectual property of AEZS-150 in development for the potential treatment of chronic hypoparathyroidism –
Epizyme (EPZM) Reports Q4 Loss, Misses Revenue Estimates
02:05pm, Tuesday, 01'st Mar 2022 Zacks Investment Research
Epizyme (EPZM) delivered earnings and revenue surprises of -19.51% and 50.55%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Top Stock Picks for the Day: Aeterna Zentaris Inc. (NASDAQ:AEZS), Team, Inc. (NYSE:TISI)
03:17am, Wednesday, 23'rd Feb 2022 Stock Equity
Aeterna Zentaris Inc. (NASDAQ:AEZS) with the stream of -2.85% also noticed, India Team, Inc. (NYSE:TISI) encountered a rapid change of -8.38% in the last hour of Tuesdays trading session. Aeterna The post Top Stock Picks for the Day: Aeterna Zentaris Inc. (NASDAQ:AEZS), Team, Inc. (NYSE:TISI) appeared first on Stocks Equity .
Remarkable Stock in Review: Synchronoss Technologies, Inc. (NASDAQ:SNCR), Aeterna Zentaris Inc. (NASDAQ:AEZS)
12:30am, Tuesday, 08'th Feb 2022 Stock Equity
Synchronoss Technologies, Inc. (NASDAQ:SNCR) with the stream of -2.88% also noticed, India Aeterna Zentaris Inc. (NASDAQ:AEZS) encountered a rapid change of 1.94% in the last hour of Mondays trading session. The post Remarkable Stock in Review: Synchronoss Technologies, Inc. (NASDAQ:SNCR), Aeterna Zentaris Inc. (NASDAQ:AEZS) appeared first on Stocks Equity .
Aeterna Zentaris to Present at the 2022 BIO CEO & Investor Conference
01:05pm, Monday, 07'th Feb 2022 GlobeNewswire Inc.
CHARLESTON, S.C., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commer
Aeterna Zentaris to Present at the 2022 BIO CEO & Investor Conference
08:05am, Monday, 07'th Feb 2022
CHARLESTON, S.C., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commerci